RIAS
PCVX icon

Rachor Investment Advisory Services’s Vaxcyte PCVX Stock Holding History

Rachor Investment Advisory Services’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$233 – 355
2026
Q1 		$233 Hold
4
– – ﹤0.01% 430
2025
Q4 		$185 Buy
+4
New +$179 ﹤0.01% 397

Other funds holding PCVX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Rachor Investment Advisory Services's PCVX Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 4 shares — an estimated $233 sold.

Rachor Investment Advisory Services first reported a position in PCVX in Q4 2025 and held it in 2 quarters. The position peaked at $233 in Q1 2026. 98 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 4 Vaxcyte shares in Q2 2026, an estimated $233.
  • Rachor Investment Advisory Services first reported a position in Vaxcyte in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Vaxcyte position peaked at $233 in Q1 2026.
  • 98 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.